Previous Close | 1.1700 |
Open | 1.1600 |
Bid | 1.2100 x 1200 |
Ask | 1.2600 x 800 |
Day's Range | 1.1500 - 1.1800 |
52 Week Range | 0.6740 - 9.6000 |
Volume | |
Avg. Volume | 1,833,738 |
Market Cap | 12.25M |
Beta (5Y Monthly) | 0.74 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.4300 |
Earnings Date | May 13, 2024 - May 17, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for ABVC
FREMONT CA - (NewMediaWire) - March 14, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a biotechnology company specializing in botanically based solutions that deliver high efficacy and low toxicity to improve health outcomes, announced its ...
FREMONT, CA - (NewMediaWire) - February 27, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology,...
FREMONT, CA - (NewMediaWire) - February 15, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced today that...